Overview

Reduction of Intrapartum Fever With Intravenous Acetaminophen

Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The investigators plan to administer acetaminophen (Tylenol) for the treatment of fever in laboring patients by either an oral or intravenous (IV) route. The investigators want to see if the maternal fever will decrease faster with the IV or the oral dose. The investigators also want to look at other outcomes such as the cesarean section rate, the rate of neonatal intensive care unit admissions in both groups.
Phase:
Phase 2
Details
Lead Sponsor:
Richmond University Medical Center
Treatments:
Acetaminophen